Clinical Trials · NCT04559815
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practice
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 194
- Start date
- Oct 2020
- Locations
- 2 sites, Canada
- Primary endpoint
- Change in Glycated haemoglobin (HbA1c)